PMS43 COST-UTILITY AND MULTINOMIAL EXPECTED VALUE OF PERFECT INFORMATION OF SEQUENCED TREATMENT WITH BIOLOGICS IN MODERATE-TO-SEVERE RHEUMATOID ARTHRITIS- ANALYSIS BASED ON CLINICALLY MEANINGFUL RESPONSES

Nov 1, 2010, 00:00
10.1016/S1098-3015(11)72196-9
https://www.valueinhealthjournal.com/article/S1098-3015(11)72196-9/fulltext
Title : PMS43 COST-UTILITY AND MULTINOMIAL EXPECTED VALUE OF PERFECT INFORMATION OF SEQUENCED TREATMENT WITH BIOLOGICS IN MODERATE-TO-SEVERE RHEUMATOID ARTHRITIS- ANALYSIS BASED ON CLINICALLY MEANINGFUL RESPONSES
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)72196-9&doi=10.1016/S1098-3015(11)72196-9
First page : A310
Section Title : RESEARCH POSTER ABSTRACTS
Open access? : No
Section Order : 354
Categories :
Tags :
Regions :
ViH Article Tags :